As an increasingly vital ingredient in the development of new drugs, devices, and diagnostics, data is creating new opportunities for collaboration. The proliferation of data creates challenges in structuring these partnerships because of the unique regulatory, privacy and cybersecurity issues involved. This panel will focus on how partners can create new products using data in this complex and evolving regulatory landscape.
Moderator, Jiayan Chen, Partner, McDermott Will & Emery
Eric Bowlin, Partner, Deloitte & Touche LLP
Ed Esplin, Clinical Geneticist, Invitae
Debbie Lin, Executive Director, Boehringer-Ingelheim Venture Fund
Sadiqa Mahmood, Senior Vice President of Medical Affairs, Health Catalyst
Emmanuelle Trombe, Partner, McDermott Will & Emery